Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D10NS is a hypertonic intravenous solution consisting of 10% dextrose in normal saline (0.9% sodium chloride). It contains 10 grams of dextrose per 100 mL of normal saline, making it more concentrated than standard D5NS. As a hypertonic solution, it must be administered carefully, preferably through a large vein to minimize venous irritation. **Clinical Uses:** * Treatment of hypoglycemia (blood sugar < 60 mg/dL or 60-80 mg/dL with symptoms) * Management of patients in PEA (Pulseless Electrical Activity) or asystole with suspected hypoglycemia * Providing both calories (from dextrose) and electrolytes (from normal saline) simultaneously * As a source of water and calories for patients who cannot take oral fluids **Administration:** * Typical adult dosage for hypoglycemia: 25 grams of dextrose in 250 mL solution administered intravenously. * Pediatric dosage: 5 mL/kg of D10 solution (maximum 250 mL) intravenously or intraosseously. * Administered through a peripheral IV or intraosseous (IO) line. * For peripheral administration, recommended to use a small-bore needle into a large vein to minimize irritation. **Precautions and Monitoring:** * Monitor the IV site for extravasation. * Monitor blood glucose levels and mental status frequently (e.g., every 5 minutes). * Potential side effects including hyperglycemia, warmth/burning from IV injection, diuresis, thrombophlebitis, and tissue necrosis if IV/IO infiltrates. * Consider central venous access for long-term administration of hypertonic dextrose solutions. **Contraindications:** * Patients with known hypersensitivity to dextrose, corn, or corn products. * Patients with hyperglycemia. * Use with caution in patients at risk for fluid overload, electrolyte imbalances, or those with renal impairment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on D10NS.